Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Quickcomparison

Dose Range Cathelicidin (hCAP-18 / Synthetic Derivatives) 0.5–5 mg LL-37 0.5–1.6 mg/mL (topical) Frequency Once daily Administration Topical application (primary research route) Topical application (wound healing) Cycle Length 4-6 weeks 12+ weeks Onset Speed R

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Dose Range
  • Cathelicidin (hCAP-18 / Synthetic Derivatives)
  • 0.5–5 mg
  • LL-37
  • 0.5–1.6 mg/mL (topical)
  • Frequency
  • Once daily
  • Administration
  • Topical application (primary research route)
  • Topical application (wound healing)
  • Cycle Length
  • 4-6 weeks
  • 12+ weeks
  • Onset Speed
  • Rapid (hours to days)
  • Moderate (1-2 weeks)
  • Evidence Level
  • Moderate human trials (Phase 1-2)
  • Efficacy